INIS
cancer
100%
patients
91%
rectum
52%
radiotherapy
41%
tumors
35%
esophagus
35%
doses
31%
volume
23%
brachytherapy
21%
combined therapy
20%
radiations
15%
comparative evaluations
14%
metastases
13%
risks
13%
therapy
13%
diseases
12%
data
12%
prediction
12%
validation
12%
surgery
11%
positron computed tomography
11%
toxicity
10%
nmr imaging
9%
lymph nodes
9%
guidelines
9%
protons
8%
reviews
8%
quality of life
8%
learning
8%
chemotherapy
8%
Keyphrases
Colorectal Cancer
32%
Esophageal Cancer
28%
Radiotherapy
21%
Neoadjuvant Chemoradiotherapy (nCRT)
18%
Chemoradiotherapy
12%
Cancer Patients
11%
Brachytherapy
11%
Chemoradiation
10%
Tumor
10%
Locally Advanced Rectal Cancer
9%
Dose Escalation
8%
Locally Recurrent Rectal Cancer
8%
Overall Survival
8%
Contact X-ray Brachytherapy
7%
Prediction Model
7%
Treatment Verification
6%
Neoadjuvant
6%
Proton Therapy
6%
PET-MRI
6%
Esophagogastric Cancer
6%
Oligometastatic
6%
Netherlands
6%
Watch-and-wait
5%
Treatment Planning
5%
Delineation Guidelines
5%
Papillon
5%
External Validation
5%
External Beam Radiotherapy
5%
Medicine and Dentistry
Rectum Cancer
40%
Chemoradiotherapy
35%
Radiation Therapy
31%
Neoplasm
23%
Brachytherapy
18%
Diseases
13%
Esophageal Cancer
13%
Malignant Neoplasm
11%
Overall Survival
9%
Esophageal Cancer
8%
Arm
8%
Lymph Node
7%
Quality of Life
6%
Patient-Reported Outcome
6%
Magnetic Resonance Imaging
6%
Primary Tumor
5%
External Beam Radiotherapy
5%
Iridium 192
5%
